3/25
12:32 pm
mxct
MaxCyte (MXCT) had its price target lowered by Craig Hallum from $7.00 to $5.00. They now have a "buy" rating on the stock.
Medium
Report
MaxCyte (MXCT) had its price target lowered by Craig Hallum from $7.00 to $5.00. They now have a "buy" rating on the stock.
3/25
02:19 am
mxct
MaxCyte outlines $30M–$32M 2026 revenue target as ExPERT DTx launch and SPL milestones drive outlook [Seeking Alpha]
Low
Report
MaxCyte outlines $30M–$32M 2026 revenue target as ExPERT DTx launch and SPL milestones drive outlook [Seeking Alpha]
3/25
02:15 am
mxct
MaxCyte, Inc. (MXCT) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
MaxCyte, Inc. (MXCT) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/24
11:07 pm
mxct
MaxCyte Inc (MXCT) Q4 2025 Earnings Call Highlights: Navigating Revenue Declines Amid Strategic ... [Yahoo! Finance]
Low
Report
MaxCyte Inc (MXCT) Q4 2025 Earnings Call Highlights: Navigating Revenue Declines Amid Strategic ... [Yahoo! Finance]
3/24
06:01 pm
mxct
MaxCyte (MXCT) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
MaxCyte (MXCT) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
3/24
05:57 pm
mxct
MaxCyte Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
MaxCyte Q4 Earnings Call Highlights [Yahoo! Finance]
3/24
04:13 pm
mxct
MaxCyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance [Yahoo! Finance]
Low
Report
MaxCyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance [Yahoo! Finance]
3/24
04:05 pm
mxct
MaxCyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance
Medium
Report
MaxCyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance
3/24/2026
04:05 pm
mxct
maxcyte, inc.
MISS
Report
-6.8%
maxcyte, inc.
11/12/2025
04:05 pm
mxct
maxcyte, inc.
MISS
Report
-1.9%
maxcyte, inc.
8/6/2025
04:05 pm
mxct
maxcyte, inc.
BEAT
Report
-29.9%
maxcyte, inc.
5/7/2025
04:05 pm
mxct
maxcyte, inc.
IN-LINE
Report
-11.3%
maxcyte, inc.
3/27
04:55 pm
mxct
Form 8-K MAXCYTE, INC. For: Mar 23
Low
Report
Form 8-K MAXCYTE, INC. For: Mar 23
3/27
10:34 am
mxct
Form SCHEDULE 13G/A MAXCYTE, INC. Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A MAXCYTE, INC. Filed by: VANGUARD GROUP INC
3/25
04:37 pm
mxct
Form 10-K MAXCYTE, INC. For: Dec 31
Medium
Report
Form 10-K MAXCYTE, INC. For: Dec 31
3/24
04:15 pm
mxct
Form 8-K MAXCYTE, INC. For: Mar 24
Low
Report
Form 8-K MAXCYTE, INC. For: Mar 24
3/20
04:40 pm
mxct
Form 8-K MAXCYTE, INC. For: Mar 16
Medium
Report
Form 8-K MAXCYTE, INC. For: Mar 16
3/19
04:06 pm
mxct
Form 4 MAXCYTE, INC. For: Mar 17 Filed by: Swirsky Douglas J
Medium
Report
Form 4 MAXCYTE, INC. For: Mar 17 Filed by: Swirsky Douglas J
2/17
02:29 pm
mxct
Form SCHEDULE 13G/A MAXCYTE, INC. Filed by: CADIAN CAPITAL MANAGEMENT, LP
Low
Report
Form SCHEDULE 13G/A MAXCYTE, INC. Filed by: CADIAN CAPITAL MANAGEMENT, LP
2/5
08:04 am
mxct
Form SCHEDULE 13G MAXCYTE, INC. Filed by: Capricorn Fund Managers Ltd
Medium
Report
Form SCHEDULE 13G MAXCYTE, INC. Filed by: Capricorn Fund Managers Ltd
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register